The Valley Desk

NCT04269200 · Interventional trial

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

Overall registry status Active not recruiting

Phase 3

Conditions Endometrial Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov